Evidence map›Paper›PMID 30090292›Full record

ArticleChemical science2018

Correction: Spironaphthoxazine switchable dyes for biological imaging.

Yaoyao Xiong, Andreas Vargas Jentzsch, Johannes W M Osterrieth, Erdinc Sezgin, Igor V Sazanovich, Katharina Reglinski, Silvia Galiani, Anthony W Parker, Christian Eggeling, Harry L Anderson

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yaoyao XiongDepartment of Chemistry , University of Oxford , Chemistry Research Laboratory , Oxford OX1 3TA , UK . Email: harry.anderson@chem.ox.ac.uk.
Andreas Vargas JentzschDepartment of Chemistry , University of Oxford , Chemistry Research Laboratory , Oxford OX1 3TA , UK . Email: harry.anderson@chem.ox.ac.uk.
Johannes W M OsterriethDepartment of Chemistry , University of Oxford , Chemistry Research Laboratory , Oxford OX1 3TA , UK . Email: harry.anderson@chem.ox.ac.uk.
Erdinc SezginMRC Human Immunology Unit , Weatherall Institute of Molecular Medicine , University of Oxford , OX3 9DS , Oxford , UK.
Igor V SazanovichCentral Laser Facility , Research Complex at Harwell , Science and Technology Facilities Council , Harwell Campus , Didcot OX11 0QX , UK.
Katharina ReglinskiMRC Human Immunology Unit , Weatherall Institute of Molecular Medicine , University of Oxford , OX3 9DS , Oxford , UK.
Silvia GalianiMRC Human Immunology Unit , Weatherall Institute of Molecular Medicine , University of Oxford , OX3 9DS , Oxford , UK.
Anthony W ParkerCentral Laser Facility , Research Complex at Harwell , Science and Technology Facilities Council , Harwell Campus , Didcot OX11 0QX , UK.
Christian EggelingMRC Human Immunology Unit , Weatherall Institute of Molecular Medicine , University of Oxford , OX3 9DS , Oxford , UK.
Harry L AndersonDepartment of Chemistry , University of Oxford , Chemistry Research Laboratory , Oxford OX1 3TA , UK . Email: harry.anderson@chem.ox.ac.uk.

Funding

Medical Research Council G0902418Medical Research Council MC_UU_00008/9Medical Research Council MC_UU_12010/9
6 · The paper itself

Abstract

[This corrects the article DOI: 10.1039/C8SC00130H.].

Identifiers

PMID30090292
PMCPMC6062417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.